Oklahoma Senate Bill SB1221

Oklahoma 2022 Regular Session

• Introduced: 2/7/22
• Refer: 2/8/22

Caption

Practice of pharmacy; authorizing pharmacist to enter into certain collaborative practice agreements. Effective date.

Impact

If enacted, SB1221 would amend existing pharmacy practice laws to allow for more comprehensive team-based approaches to healthcare delivery. By legitimizing collaborative efforts between pharmacists and practitioners, this bill could lead to improved medication management, increased opportunities for patient education, and better overall health outcomes for patients. It positions pharmacists as integral members of the healthcare team, which may also alleviate some burdens on primary care providers.

Summary

Senate Bill 1221 focuses on expanding the role of pharmacists in patient care by allowing them to enter into collaborative practice agreements with licensed practitioners. This formalizes the relationship between pharmacists and healthcare providers, enabling pharmacists to perform specific patient care functions under protocols established in these agreements. The bill intends to enhance patient access to care and streamline treatment processes in the state of Oklahoma, particularly in pharmacy settings.

Contention

Discussion around SB1221 may have included various viewpoints regarding the extent of authority granted to pharmacists. Some stakeholders might express concerns regarding the classification of specific patient care functions that pharmacists could perform. This could raise questions about qualifications and training, as well as potential risks associated with expanded pharmacist interventions in patient care. Balancing patient safety with increased pharmacist involvement is likely to be a key point of contention during deliberations on this bill.